qimaite tramadol hydrochloride injection 1ml50mg per vial

Description

Indication & Scope

QiMaiTe® is a prescription opioid analgesic indicated for the management of moderate to severe acute and chronic pain, including postoperative pain, cancer pain, trauma-related pain, and other conditions requiring injectable analgesia when non-opioid therapy is inadequate.

Mechanism: Tramadol is a centrally acting analgesic that weakly stimulates μ-opioid receptors while inhibiting the reuptake of norepinephrine and serotonin, providing dual-pathway pain relief.
Drug class: Centrally acting opioid analgesic.
Clinical use: Management of moderate to severe acute or chronic pain, including postoperative, cancer-related, traumatic, and musculoskeletal pain.

Specification

Generic Name	Tramadol Hydrochloride Injection
Brand Name	QiMaiTe®
Ingredient	Tramadol Hydrochloride
Dosage Form	Injection
Package	50 mg : 1 mL/vial/box
Conditions Treated	Moderate to severe pain
Taboos	Hypersensitivity to tramadol; acute intoxication with alcohol, opioids or sedatives; MAOI use within 14 days; severe respiratory depression
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 25°C in a protected place away from light.
Manufacturer	CSPC Ouyi Pharmaceutical Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20258116
Approval Date	September 24, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Adults: 50–100 mg administered by intramuscular, subcutaneous, or slow intravenous injection every 4–6 hours as needed. The maximum recommended daily dose is generally 400 mg.

Time: Administer every 4–6 hours as needed. For intravenous administration, inject slowly over at least 2 minutes.

Instructions for use: Administer only under medical supervision. Use the lowest effective dose for the shortest duration necessary. Reduce the dose gradually if long-term therapy is discontinued.

Interaction: Avoid concomitant use with alcohol, benzodiazepines, MAO inhibitors, other opioids, and serotonergic drugs because of the increased risk of respiratory depression, excessive sedation, or serotonin syndrome.

Side effects: Common adverse reactions include nausea, vomiting, dizziness, drowsiness, sweating, constipation, and headache. Serious adverse reactions include respiratory depression, seizures, serotonin syndrome, hypotension, and drug dependence.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is QiMaiTe® (Tramadol Hydrochloride Injection) used for?

QiMaiTe® is indicated for the treatment of moderate to severe acute and chronic pain, including postoperative pain, cancer pain, fracture pain, and traumatic pain.

Is QiMaiTe® (Tramadol Hydrochloride Injection) an opioid medicine?

Yes. Tramadol is a centrally acting opioid analgesic with dual mechanisms of action and is classified as a Class II psychotropic medicine in China.

Can QiMaiTe® (Tramadol Hydrochloride Injection) be used with alcohol or sedatives?

No. Alcohol, benzodiazepines, and other CNS depressants should be avoided because they significantly increase the risk of excessive sedation and respiratory depression.

Can QiMaiTe® (Tramadol Hydrochloride Injection) cause dependence?

Long-term or high-dose use may lead to physical dependence. Treatment should always follow a physician’s instructions, and prolonged therapy should not be stopped abruptly.